Regenerative therapy
ProcedurePeriosteal pedicle, Platelets rich fibrin
Other names: Guided tissue regeneration
NCT Number: NCT02359539
The use of autogenous graft materials has been recorded to be a gold standard in regenerative therapy. This study directed toward evaluation of two autogenous regenerative materials, marginal periosteal pedicle graft (MPP) and platelet rich fibrin (PRF) as membrane barriers for treating intrabony defects. In spite of its reported significant clinical outcomes, the limited availability of the periosteum makes it necessary to evaluate other autogenous alternatives such as PRF that could offer predictable outcomes.
Looking for future studies?
Notify Me20 year–50 year
All sexes
Interventional
Phase 2
Material and methods: 10 patients with sever chronic periodontitis and at least single ≥4 mm intrabony defect had participated in this randomized clinical study. Subjects were randomly divided into2 groups, Group 1(MPP) defect coverage with xenograft defect fill(10 patients),Group 2(PRF) defect coverage with xenograft defect fill(10 patients).Clinical and radiographic measurements were carried out at 3,6 and 9 months postoperatively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Periosteal pedicle, Platelets rich fibrin
Other names: Guided tissue regeneration
Time frame: 9 month after surgery
measurements of intrabony gain from CEJ to base of defect
Al-Azhar University
Other
Marginal Periosteal Pedicle Flap and Platelet Rich Fibrin Barriers for the Treatment of Periodontal Intrabony Defects -Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07700628
Mouth Diseases, Peri-Implantitis
Caserta, CE, Italy
View Trial DetailsNCT07669233
Gingival Diseases, Gingivitis
Chengdu, Sichuan, China
View Trial DetailsNCT07604636
Mouth Diseases, Periodontal Diseases
Erzurum, Turkey (Türkiye)
View Trial DetailsNCT07592377
Inflammation, Mouth Diseases
Dongo, Como, Italy
View Trial Details